In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer
Marcos Quintela(Swansea University), Lewis W. Francis(Swansea University)
Cited by 5
Related Papers
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells
|Clinical Epigenetics|2023|7
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion
|Frontiers in Cell and Developmental Biology|2025|2